MMS 10-Q Quarterly Report Dec. 31, 2023 | Alphaminr
ALPHAMINR

MMS 10-Q Quarter ended Dec. 31, 2023

Balance Sheet
Cash Flow
Income Statement
Debt
MAXIMUS, INC.
10-Ks and 10-Qs
10-K
Fiscal year ended Sept. 30, 2025
10-Q
Quarter ended June 30, 2025
10-Q
Quarter ended March 31, 2025
10-Q
Quarter ended Dec. 31, 2024
10-K
Fiscal year ended Sept. 30, 2024
10-Q
Quarter ended June 30, 2024
10-Q
Quarter ended March 31, 2024
10-Q
Quarter ended Dec. 31, 2023
10-K
Fiscal year ended Sept. 30, 2023
10-Q
Quarter ended June 30, 2023
10-Q
Quarter ended March 31, 2023
10-Q
Quarter ended Dec. 31, 2022
10-K
Fiscal year ended Sept. 30, 2022
10-Q
Quarter ended June 30, 2022
10-Q
Quarter ended March 31, 2022
10-Q
Quarter ended Dec. 31, 2021
10-K
Fiscal year ended Sept. 30, 2021
10-Q
Quarter ended June 30, 2021
10-Q
Quarter ended March 31, 2021
10-Q
Quarter ended Dec. 31, 2020
10-K
Fiscal year ended Sept. 30, 2020
10-Q
Quarter ended June 30, 2020
10-Q
Quarter ended March 31, 2020
10-Q
Quarter ended Dec. 31, 2019
10-K
Fiscal year ended Sept. 30, 2019
10-Q
Quarter ended June 30, 2019
10-Q
Quarter ended March 31, 2019
10-Q
Quarter ended Dec. 31, 2018
10-K
Fiscal year ended Sept. 30, 2018
10-Q
Quarter ended June 30, 2018
10-Q
Quarter ended March 31, 2018
10-Q
Quarter ended Dec. 31, 2017
10-K
Fiscal year ended Sept. 30, 2017
10-Q
Quarter ended June 30, 2017
10-Q
Quarter ended March 31, 2017
10-Q
Quarter ended Dec. 31, 2016
10-K
Fiscal year ended Sept. 30, 2016
10-Q
Quarter ended June 30, 2016
10-Q
Quarter ended March 31, 2016
10-Q
Quarter ended Dec. 31, 2015
10-K
Fiscal year ended Sept. 30, 2015
10-Q
Quarter ended June 30, 2015
10-Q
Quarter ended March 31, 2015
10-Q
Quarter ended Dec. 31, 2014
10-K
Fiscal year ended Sept. 30, 2014
10-Q
Quarter ended June 30, 2014
10-Q
Quarter ended March 31, 2014
10-Q
Quarter ended Dec. 31, 2013
10-K
Fiscal year ended Sept. 30, 2013
10-Q
Quarter ended June 30, 2013
10-Q
Quarter ended March 31, 2013
10-Q
Quarter ended Dec. 31, 2012
10-K
Fiscal year ended Sept. 30, 2012
10-Q
Quarter ended June 30, 2012
10-Q
Quarter ended March 31, 2012
10-Q
Quarter ended Dec. 31, 2011
10-K
Fiscal year ended Sept. 30, 2011
10-Q
Quarter ended June 30, 2011
10-Q
Quarter ended March 31, 2011
10-Q
Quarter ended Dec. 31, 2010
10-K
Fiscal year ended Sept. 30, 2010
10-Q
Quarter ended June 30, 2010
10-Q
Quarter ended March 31, 2010
10-Q
Quarter ended Dec. 31, 2009
PROXIES
DEF 14A
Filed on March 11, 2025
DEF 14A
Filed on Jan. 22, 2025
DEF 14A
Filed on March 12, 2024
DEF 14A
Filed on Jan. 24, 2024
DEF 14A
Filed on March 14, 2023
DEF 14A
Filed on Jan. 25, 2023
DEF 14A
Filed on March 15, 2022
DEF 14A
Filed on Jan. 26, 2022
DEF 14A
Filed on Jan. 27, 2021
DEF 14A
Filed on Jan. 27, 2020
DEF 14A
Filed on Jan. 25, 2019
DEF 14A
Filed on Jan. 26, 2018
DEF 14A
Filed on Jan. 27, 2017
DEF 14A
Filed on Jan. 29, 2016
DEF 14A
Filed on Jan. 26, 2015
DEF 14A
Filed on Jan. 24, 2014
DEF 14A
Filed on Jan. 25, 2013
DEF 14A
Filed on Jan. 27, 2012
DEF 14A
Filed on Jan. 25, 2011
DEF 14A
Filed on Jan. 26, 2010
mms-20231231
0001032220 09/30 2024 Q1 FALSE 1600 Tysons Boulevard McLean Virginia 703 251-8500 Large accelerated filer ☐ ☐ http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2023#OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent P3Y P3Y 105 354 0001032220 2023-10-01 2023-12-31 0001032220 2024-02-05 xbrli:shares iso4217:USD 0001032220 2022-10-01 2022-12-31 iso4217:USD xbrli:shares 0001032220 2023-12-31 0001032220 2023-09-30 0001032220 2022-09-30 0001032220 2022-12-31 0001032220 us-gaap:CommonStockMember 2023-09-30 0001032220 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001032220 us-gaap:RetainedEarningsMember 2023-09-30 0001032220 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001032220 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 2023-12-31 0001032220 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001032220 us-gaap:CommonStockMember 2023-12-31 0001032220 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001032220 us-gaap:RetainedEarningsMember 2023-12-31 0001032220 us-gaap:CommonStockMember 2022-09-30 0001032220 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001032220 us-gaap:RetainedEarningsMember 2022-09-30 0001032220 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001032220 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-01 2022-12-31 0001032220 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001032220 us-gaap:CommonStockMember 2022-12-31 0001032220 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001032220 us-gaap:RetainedEarningsMember 2022-12-31 0001032220 us-gaap:TechnologyEquipmentMember 2023-12-31 mms:segment 0001032220 mms:U.S.FederalServicesMember us-gaap:OperatingSegmentsMember 2023-10-01 2023-12-31 0001032220 mms:U.S.FederalServicesMember us-gaap:OperatingSegmentsMember 2022-10-01 2022-12-31 0001032220 us-gaap:OperatingSegmentsMember mms:USServicesMember 2023-10-01 2023-12-31 0001032220 us-gaap:OperatingSegmentsMember mms:USServicesMember 2022-10-01 2022-12-31 0001032220 mms:OutsideTheUnitedStatesMember us-gaap:OperatingSegmentsMember 2023-10-01 2023-12-31 0001032220 mms:OutsideTheUnitedStatesMember us-gaap:OperatingSegmentsMember 2022-10-01 2022-12-31 xbrli:pure 0001032220 us-gaap:MaterialReconcilingItemsMember 2023-10-01 2023-12-31 0001032220 us-gaap:MaterialReconcilingItemsMember 2022-10-01 2022-12-31 0001032220 2023-09-30 2023-09-30 0001032220 mms:PerformanceBasedContractsMember 2023-10-01 2023-12-31 0001032220 us-gaap:SalesRevenueNetMember mms:ContractConcentrationRiskMember mms:PerformanceBasedContractsMember 2023-10-01 2023-12-31 0001032220 mms:PerformanceBasedContractsMember 2022-10-01 2022-12-31 0001032220 us-gaap:SalesRevenueNetMember mms:ContractConcentrationRiskMember mms:PerformanceBasedContractsMember 2022-10-01 2022-12-31 0001032220 mms:CostPlusContractsMember 2023-10-01 2023-12-31 0001032220 us-gaap:SalesRevenueNetMember mms:ContractConcentrationRiskMember mms:CostPlusContractsMember 2023-10-01 2023-12-31 0001032220 mms:CostPlusContractsMember 2022-10-01 2022-12-31 0001032220 us-gaap:SalesRevenueNetMember mms:ContractConcentrationRiskMember mms:CostPlusContractsMember 2022-10-01 2022-12-31 0001032220 us-gaap:FixedPriceContractMember 2023-10-01 2023-12-31 0001032220 us-gaap:SalesRevenueNetMember mms:ContractConcentrationRiskMember us-gaap:FixedPriceContractMember 2023-10-01 2023-12-31 0001032220 us-gaap:FixedPriceContractMember 2022-10-01 2022-12-31 0001032220 us-gaap:SalesRevenueNetMember mms:ContractConcentrationRiskMember us-gaap:FixedPriceContractMember 2022-10-01 2022-12-31 0001032220 us-gaap:TimeAndMaterialsContractMember 2023-10-01 2023-12-31 0001032220 us-gaap:TimeAndMaterialsContractMember us-gaap:SalesRevenueNetMember mms:ContractConcentrationRiskMember 2023-10-01 2023-12-31 0001032220 us-gaap:TimeAndMaterialsContractMember 2022-10-01 2022-12-31 0001032220 us-gaap:TimeAndMaterialsContractMember us-gaap:SalesRevenueNetMember mms:ContractConcentrationRiskMember 2022-10-01 2022-12-31 0001032220 mms:UnitedStatesFederalGovernmentAgenciesMember 2023-10-01 2023-12-31 0001032220 mms:UnitedStatesFederalGovernmentAgenciesMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-10-01 2023-12-31 0001032220 mms:UnitedStatesFederalGovernmentAgenciesMember 2022-10-01 2022-12-31 0001032220 mms:UnitedStatesFederalGovernmentAgenciesMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2022-10-01 2022-12-31 0001032220 mms:TotalUnitedStatesStateGovernmentAgenciesMember 2023-10-01 2023-12-31 0001032220 mms:TotalUnitedStatesStateGovernmentAgenciesMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-10-01 2023-12-31 0001032220 mms:TotalUnitedStatesStateGovernmentAgenciesMember 2022-10-01 2022-12-31 0001032220 mms:TotalUnitedStatesStateGovernmentAgenciesMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2022-10-01 2022-12-31 0001032220 mms:InternationalGovernmentAgenciesMember 2023-10-01 2023-12-31 0001032220 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember mms:InternationalGovernmentAgenciesMember 2023-10-01 2023-12-31 0001032220 mms:InternationalGovernmentAgenciesMember 2022-10-01 2022-12-31 0001032220 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember mms:InternationalGovernmentAgenciesMember 2022-10-01 2022-12-31 0001032220 mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember 2023-10-01 2023-12-31 0001032220 mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-10-01 2023-12-31 0001032220 mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember 2022-10-01 2022-12-31 0001032220 mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2022-10-01 2022-12-31 0001032220 us-gaap:UnbilledRevenuesMember 2023-12-31 0001032220 us-gaap:UnbilledRevenuesMember 2023-09-30 0001032220 us-gaap:ChangeInAccountingMethodAccountedForAsChangeInEstimateMember 2023-10-01 2023-12-31 0001032220 2024-01-01 2023-12-31 0001032220 mms:TermLoanADue2026Member us-gaap:SecuredDebtMember 2023-12-31 0001032220 mms:TermLoanADue2026Member us-gaap:SecuredDebtMember 2023-09-30 0001032220 mms:TermLoanBDue2028Member us-gaap:SecuredDebtMember 2023-12-31 0001032220 mms:TermLoanBDue2028Member us-gaap:SecuredDebtMember 2023-09-30 0001032220 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2023-12-31 0001032220 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2023-09-30 0001032220 mms:SubsidiaryLoansMember 2023-12-31 0001032220 mms:SubsidiaryLoansMember 2023-09-30 0001032220 mms:TermLoanADue2026Member us-gaap:InterestRateSwapMember us-gaap:SecuredDebtMember 2023-12-31 0001032220 us-gaap:OtherAssetsMember 2023-12-31 0001032220 us-gaap:OtherLiabilitiesMember 2023-12-31 0001032220 us-gaap:OtherAssetsMember 2023-09-30 0001032220 mms:TermLoanADue2026Member mms:InterestRateSwap2Member us-gaap:SecuredDebtMember 2023-12-31 0001032220 us-gaap:FairValueInputsLevel1Member us-gaap:MutualFundMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001032220 us-gaap:MutualFundMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001032220 us-gaap:MutualFundMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001032220 us-gaap:MutualFundMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001032220 us-gaap:InterestRateSwapMember 2023-12-31 0001032220 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001032220 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001032220 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001032220 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001032220 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001032220 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001032220 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001032220 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001032220 us-gaap:AccumulatedTranslationAdjustmentMember 2023-09-30 0001032220 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-09-30 0001032220 us-gaap:AccumulatedTranslationAdjustmentMember 2023-10-01 2023-12-31 0001032220 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-10-01 2023-12-31 0001032220 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001032220 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0001032220 mms:NavientMember srt:MaximumMember 2021-10-31 0001032220 mms:AidvantageNavientMember 2023-12-31 0001032220 mms:AidvantageNavientMember 2023-09-30 0001032220 mms:BZBodiesLimitedMember 2023-12-31 0001032220 mms:BZBodiesLimitedMember 2023-09-30 iso4217:GBP 0001032220 us-gaap:RestrictedStockUnitsRSUMember mms:A2021StockIncentivePlanMember srt:MinimumMember 2023-10-01 2023-12-31 0001032220 us-gaap:RestrictedStockUnitsRSUMember mms:A2021StockIncentivePlanMember srt:MaximumMember 2023-10-01 2023-12-31 0001032220 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember mms:A2021StockIncentivePlanMember 2023-10-01 2023-12-31 0001032220 mms:A2021StockIncentivePlanMember srt:MinimumMember us-gaap:PerformanceSharesMember 2023-10-01 2023-12-31 0001032220 mms:A2021StockIncentivePlanMember srt:MaximumMember us-gaap:PerformanceSharesMember 2023-10-01 2023-12-31 0001032220 us-gaap:PerformanceSharesMember 2023-10-01 2023-12-31 0001032220 us-gaap:RestrictedStockUnitsRSUMember 2023-10-01 2023-12-31 0001032220 us-gaap:RestrictedStockUnitsRSUMember srt:MinimumMember 2023-10-01 2023-12-31 0001032220 us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember 2023-10-01 2023-12-31 0001032220 us-gaap:BilledRevenuesMember 2023-12-31 0001032220 us-gaap:BilledRevenuesMember 2023-09-30 0001032220 2022-09-21 0001032220 mms:MOVEitFederalCourtMember 2023-12-31 mms:case 0001032220 mms:MOVEitStateCourtMember 2023-09-06 mms:action 0001032220 mms:MOVEitStateCourtMember 2023-09-06 2023-09-06 0001032220 us-gaap:SubsequentEventMember 2024-01-05 2024-01-05 0001032220 srt:ScenarioForecastMember us-gaap:CommonStockMember 2024-02-29 2024-02-29 0001032220 mms:DavidWMutrynMember 2023-10-01 2023-12-31 0001032220 mms:DavidWMutrynMember 2023-12-31 0001032220 mms:MichelleLinkMember 2023-10-01 2023-12-31 0001032220 mms:MichelleLinkMember 2023-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
(Mark one)
☒ Q UARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2023
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________to__________.
Commission file number: 1-12997
Maximus_logo_2022.jpg

Maximus, Inc.
(Exact name of registrant as specified in its charter)
Virginia 54-1000588
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
1600 Tysons Boulevard , McLean , Virginia
22102
(Address of principal executive offices)
(Zip Code)
( 703 ) 251-8500
(Registrant's telephone number, including the area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, no par value MMS New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☒
Accelerated filer ☐
Non-accelerated filer ☐
Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
There were 61,031,447 shares of the registrant's Common Stock outstanding as of February 5, 2024.

Table of Contents to First Quarter 2024 Form 10-Q

2
Unless otherwise specified, references in this Quarterly Report on Form 10-Q to "our," "we," "us," "Maximus," the "Company," and "our business" refer to Maximus, Inc. and its subsidiaries.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Included in this Quarterly Report on Form 10-Q are forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "opportunity," "could," "potential," "believe," "project," "estimate," "expect," "continue," "forecast," "strategy," "future," "likely," "may," "should," "will," and similar references to future periods.
Any statements herein that are not historical facts, including statements about our confidence, strategies and initiatives, and our expectations about revenues, results of operations, profitability, liquidity, market demand, and our recent acquisitions and divestitures, are forward-looking statements that are subject to risks and uncertainties. These risks could cause our actual results to differ materially from those indicated by such forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:
• a failure to meet performance requirements could lead to penalties, liquidated damages, actual damages, adverse settlement agreements, and/or contract termination;
• our ability to successfully compete, bid for, and accurately price contracts to generate our desired profit;
• the effects of future legislative or government budgetary and spending changes;
• the impact of the U.S. government on federal procurement, federal funding to states' safety-net programs, and the overall decision-making process related to our industry, including our business and customers;
• our ability to manage our growth, including acquired businesses;
• difficulties in integrating or achieving projected revenues, earnings, and other benefits associated with acquired businesses;
• the outcome of reviews or audits, which might result in financial penalties and impair our ability to respond to invitations for new work;
• our ability to manage capital investments and startup costs incurred before receiving related contract payments;
• our ability to manage our debt;
• our ability to maintain technology systems and otherwise protect confidential or protected information;
• our discovery of additional information related to the previously disclosed cybersecurity incident and any potential legal, business, reputational, or financial consequences resulting from the incident;
• our ability to attract and retain executive officers, senior managers, and other qualified personnel to execute our business;
• the ability of government customers to terminate contracts on short notice, with or without cause;
• our ability to maintain relationships with key government entities from whom a substantial portion of our revenue is derived;
• a failure to comply with laws governing our business, which might result in the Company being subject to fines, penalties, suspension, debarment, and other sanctions;
• the costs and outcome of litigation;
• our ability to manage third parties upon whom we depend to provide services to our customers;
• the effects of changes in laws and regulations governing our business, including tax laws and applicable interpretations and guidance thereunder, or changes in accounting policies, rules, methodologies, and practices, and our ability to estimate the impact of such changes;
• our ability to manage emerging artificial intelligence and machine learning technologies;
• matters related to businesses we disposed of or divested; and
• other factors set forth in Item 1A, "Risk Factors" of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission on November 16, 2023.
Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, or otherwise.
3
PART I - Financial Information
Item 1. Financial Statements
Maximus, Inc.
Consolidated Statements of Operations
(Unaudited)
For the Three Months Ended
December 31, 2023 December 31, 2022
(in thousands, except per share amounts)
Revenue $ 1,327,041 $ 1,249,246
Cost of revenue 1,026,987 1,004,499
Gross profit 300,054 244,747
Selling, general, and administrative expenses 169,195 146,452
Amortization of intangible assets 23,349 23,518
Operating income 107,510 74,777
Interest expense 21,507 21,606
Other expense/(income), net 488 ( 266 )
Income before income taxes 85,515 53,437
Provision for income taxes 21,367 13,442
Net income $ 64,148 $ 39,995
Earnings per share:
Basic $ 1.05 $ 0.65
Diluted $ 1.04 $ 0.65
Weighted average shares outstanding:
Basic 61,322 61,117
Diluted 61,535 61,196
Dividends declared per share $ 0.30 $ 0.28
See accompanying notes to consolidated financial statements.
4
Maximus, Inc.
Consolidated Statements of Comprehensive Income
(Unaudited)
For the Three Months Ended
December 31, 2023 December 31, 2022
(in thousands)
Net income $ 64,148 $ 39,995
Other comprehensive (loss)/income, net of tax:
Foreign currency translation adjustments 5,912 8,036
Net losses on cash flow hedges, net of tax effect of $( 3,169 ) and $( 1,349 ), respectively
( 8,885 ) ( 3,781 )
Other comprehensive (loss)/income ( 2,973 ) 4,255
Comprehensive income $ 61,175 $ 44,250
See accompanying notes to consolidated financial statements.
5
Maximus, Inc.
Consolidated Balance Sheets
December 31, 2023 September 30, 2023
(unaudited)
(in thousands)
Assets:
Cash and cash equivalents $ 104,186 $ 65,405
Accounts receivable, net 860,409 826,873
Income taxes receivable 15,850 16,556
Prepaid expenses and other current assets 129,174 146,632
Total current assets 1,109,619 1,055,466
Property and equipment, net 34,976 38,831
Capitalized software, net 125,383 107,811
Operating lease right-of-use assets 154,929 163,929
Goodwill 1,781,092 1,779,215
Intangible assets, net 680,309 703,648
Deferred contract costs, net 46,439 45,372
Deferred compensation plan assets 47,273 42,919
Deferred income taxes 2,204 2,459
Other assets 34,637 46,147
Total assets $ 4,016,861 $ 3,985,797
Liabilities and Shareholders' Equity:
Liabilities:
Accounts payable and accrued liabilities $ 267,623 $ 282,081
Accrued compensation and benefits 115,864 194,251
Deferred revenue, current portion 63,032 60,477
Income taxes payable 23,717 451
Long-term debt, current portion 90,443 86,844
Operating lease liabilities, current portion 48,490 49,852
Other current liabilities 49,197 49,058
Total current liabilities 658,366 723,014
Deferred revenue, non-current portion 37,221 38,849
Deferred income taxes 198,317 203,898
Long-term debt, non-current portion 1,222,243 1,163,149
Deferred compensation plan liabilities, non-current portion 51,507 46,432
Operating lease liabilities, non-current portion 118,594 129,367
Other liabilities 12,807 13,253
Total liabilities 2,299,055 2,317,962
Commitments and contingencies (Note 10)
Shareholders' equity:
Common stock, no par value; 100,000 shares authorized; 61,031 and 60,998 shares issued and outstanding as of December 31, 2023 and September 30 2023, respectively
585,278 577,898
Accumulated other comprehensive loss ( 30,588 ) ( 27,615 )
Retained earnings 1,163,116 1,117,552
Total shareholders' equity 1,717,806 1,667,835
Total liabilities and shareholders' equity $ 4,016,861 $ 3,985,797
See accompanying notes to consolidated financial statements.
6
Maximus, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
For the Three Months Ended
December 31, 2023 December 31, 2022
(in thousands)
Cash flows from operating activities:
Net income $ 64,148 $ 39,995
Adjustments to reconcile net income to cash flows from operations:
Depreciation and amortization of property, equipment, and capitalized software 8,411 12,280
Amortization of intangible assets 23,349 23,518
Amortization of debt issuance costs and debt discount 601 1,034
Deferred income taxes ( 2,165 ) ( 1,331 )
Stock compensation expense 9,427 4,403
Loss on sale of a businesses 1,018 —
Change in assets and liabilities, net of effects of business combinations:
Accounts receivable ( 35,379 ) ( 200,749 )
Prepaid expenses and other current assets 10,056 10,624
Deferred contract costs ( 888 ) ( 1,013 )
Accounts payable and accrued liabilities ( 15,543 ) 3,642
Accrued compensation and benefits ( 67,392 ) ( 53,271 )
Deferred revenue 877 14,764
Income taxes 22,250 9,465
Operating lease right-of-use assets and liabilities ( 1,088 ) ( 948 )
Other assets and liabilities 3,926 2,928
Net cash provided by/(used in) operating activities 21,608 ( 134,659 )
Cash flows from investing activities:
Purchases of property and equipment and capitalized software ( 22,247 ) ( 15,697 )
Proceeds from divestitures 1,815 —
Net cash used in investing activities ( 20,432 ) ( 15,697 )
Cash flows from financing activities:
Cash dividends paid to Maximus shareholders ( 18,299 ) ( 17,017 )
Tax withholding related to RSU vesting ( 13,455 ) ( 8,475 )
Payments for contingent consideration ( 2,819 ) ( 1,415 )
Proceeds from borrowings 228,409 268,702
Principal payments for debt ( 166,658 ) ( 61,355 )
Cash-collateralized escrow liabilities 1,204 ( 9,473 )
Net cash provided by financing activities 28,382 170,967
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 1,846 2,421
Net change in cash, cash equivalents, and restricted cash 31,404 23,032
Cash, cash equivalents, and restricted cash, beginning of period 122,091 136,795
Cash, cash equivalents, and restricted cash, end of period $ 153,495 $ 159,827
See accompanying notes to consolidated financial statements.
7
Maximus, Inc.
Consolidated Statements of Changes in Shareholders' Equity
(Unaudited)
Common Stock Accumulated
Other
Comprehensive
Loss 		Retained
Earnings 		Total
Equity
Shares Amount
(in thousands)
Balance at September 30, 2023 60,998 $ 577,898 $ ( 27,615 ) $ 1,117,552 $ 1,667,835
Net income — — — 64,148 64,148
Foreign currency translation — — 5,912 — 5,912
Cash flow hedge, net of tax — — ( 8,885 ) — ( 8,885 )
Cash dividends — — — ( 18,299 ) ( 18,299 )
Dividends on RSUs — 285 — ( 285 ) —
Stock compensation expense — 9,427 — — 9,427
Tax withholding adjustment related to RSU vesting — ( 2,332 ) — — ( 2,332 )
RSUs vested 33 — — — —
Balance as of December 31, 2023 61,031 $ 585,278 $ ( 30,588 ) $ 1,163,116 $ 1,717,806
Common Stock Accumulated
Other
Comprehensive
Loss 		Retained
Earnings 		Total
Equity
Shares Amount
(in thousands)
Balance at September 30, 2022 60,774 $ 557,978 $ ( 33,961 ) $ 1,025,354 $ 1,549,371
Net income — — — 39,995 39,995
Foreign currency translation — — 8,036 — 8,036
Cash flow hedge, net of tax — — ( 3,781 ) — ( 3,781 )
Cash dividends — — — ( 17,017 ) ( 17,017 )
Dividends on RSUs — 298 — ( 298 ) —
Stock compensation expense — 4,403 — — 4,403
Balance as of December 31, 2022 60,774 $ 562,679 $ ( 29,706 ) $ 1,048,034 $ 1,581,007
See accompanying notes to consolidated financial statements.
8
Maximus, Inc.
Notes to the Consolidated Financial Statements
1. ORGANIZATION
Maximus, a Virginia corporation established in 1975, is a leading provider of government services worldwide. Under our mission of Moving People Forward , we help millions of people access the vital government services they need. With over 45 years of experience working with local, state, federal, and international government clients, we proudly design, develop, and deliver innovative and impactful programs that change lives. We are driven to strengthen communities and improve the lives of those we serve. We are a proud partner to government agencies in the United States ("U.S.") and worldwide.

2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying consolidated financial statements, including the notes, include the accounts of the Company and its wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"), and the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). All intercompany balances and transactions have been eliminated in consolidation.
Basis of Presentation for Interim Periods
Certain information and footnote disclosures normally included for the annual financial statements to be prepared in accordance with U.S. GAAP have been condensed or omitted for the interim periods presented. We believe that the unaudited interim financial statements include all adjustments (which are normal and recurring in nature) necessary to present fairly our financial position and the results of operations and cash flows for the periods presented.
The results of operations for the interim periods presented are not necessarily indicative of results that may be expected for the year or future periods. The financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto for the year ended September 30, 2023, included in our Annual Report on Form 10-K for the fiscal year then ended (the "2023 10-K"). We have continued to follow the accounting policies set forth in those financial statements.
Use of Estimates
The preparation of these financial statements, in conformity with U.S. GAAP, requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenue and expenses. At each reporting period end, we make estimates, including those related to revenue recognition and cost estimation on certain contracts, the realizability of long-lived assets, including goodwill, and amounts related to income taxes, certain accrued liabilities, and contingencies and litigation.
Our capitalized software balance includes $ 26.8 million related to technology for new services within our U.S. Services Segment. We continue to evaluate these assets by comparing their carrying value to our estimated future cash flows. At this time, our probability-weighted undiscounted cash flows continue to show that we will recover the costs of these assets through our contract pipeline. It is possible that changes in our estimates of future cash flows related to these assets may change and result in the need to adjust the value of these assets.


9
3. BUSINESS SEGMENTS
We conduct our operations through three business segments: U.S. Federal Services, U.S. Services, and Outside the U.S.
U.S. Federal Services
Our U.S. Federal Services Segment delivers end-to-end solutions that help various U.S. federal government agencies better deliver on their mission, including program operations and management, clinical services, and technology solutions. This segment also includes appeals and assessments services, system and application development, Information Technology ("IT") modernization, and maintenance services. Certain state-based assessments and appeals work that is part of the segment's heritage continues to be managed within this segment. Under Technology Consulting Services ("TCS"), the segment executes on its digital strategy to deliver technology solutions that advance agency missions, including the challenge to modernize, provide better customer experience, and drive process efficiencies. The segment continues to expand its clinical solutions through Veteran's Evaluation Services ("VES"), a Maximus company, which manages the clinical evaluation process for U.S. veterans and service members on behalf of the U.S. Department of Veterans Affairs ("VA").
U.S. Services
Our U.S. Services Segment provides a variety of business process services ("BPS"), such as program administration, assessments, and related consulting work for U.S. state and local government programs. These services support a variety of programs, including the Affordable Care Act ("ACA"), Medicaid, the Children's Health Insurance Program ("CHIP"), Temporary Assistance to Needy Families ("TANF"), and child support programs. Over the last three years, many programs in this segment have been operating with depressed margins resulting from the pause in Medicaid redeterminations. The depressed margins have resulted from reduced operating leverage in the segment as costs cannot scale down at the same rate to meet lower demand due to requirements to fulfill other obligations on these contracts. With the resumption of redeterminations, we expect fiscal year 2024 and beyond to reflect a recovery of operating leverage.
Outside the U.S.
Our Outside the U.S. Segment provides BPS for international governments, transforming the lives of people around the world. Helping people find employment, access vital support, and remain healthy, these services include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. We support programs and deliver services in the United Kingdom, including the Health Assessment Advisory Service ("HAAS") and the recently awarded replacement contract to start in 2024, Functional Assessment Services (“FAS”), and Restart; Australia, including Workforce Australia and employment support and job seeker services worldwide.
10
Table 3.1: Results of Operation by Business Segment
For the Three Months Ended
December 31, 2023 December 31, 2022
Amount % (1) Amount % (1)
(dollars in thousands)
Revenue:
U.S. Federal Services $ 677,078 $ 618,167
U.S. Services 489,845 439,478
Outside the U.S. 160,118 191,601
Revenue $ 1,327,041 $ 1,249,246
Gross profit:
U.S. Federal Services $ 156,662 23.1 % $ 122,694 19.8 %
U.S. Services 118,363 24.2 % 83,598 19.0 %
Outside the U.S. 25,029 15.6 % 38,455 20.1 %
Gross profit $ 300,054 22.6 % $ 244,747 19.6 %
Selling, general, and administrative expenses:
U.S. Federal Services $ 87,855 13.0 % $ 71,649 11.6 %
U.S. Services 52,300 10.7 % 45,842 10.4 %
Outside the U.S. 25,141 15.7 % 28,389 14.8 %
Divestiture-related charges (2) 1,018 NM — NM
Other (3) 2,881 NM 572 NM
Selling, general, and administrative expenses $ 169,195 12.7 % $ 146,452 11.7 %
Operating income:
U.S. Federal Services $ 68,807 10.2 % $ 51,045 8.3 %
U.S. Services 66,063 13.5 % 37,756 8.6 %
Outside the U.S. ( 112 ) ( 0.1 ) % 10,066 5.3 %
Amortization of intangible assets ( 23,349 ) NM ( 23,518 ) NM
Divestiture-related charges (2) ( 1,018 ) NM — NM
Other (3) ( 2,881 ) NM ( 572 ) NM
Operating income $ 107,510 8.1 % $ 74,777 6.0 %
(1) Percentage of respective segment revenue. Percentages not considered meaningful are marked "NM."
(2) In November 2023, we sold our businesses in Italy and Singapore, as well as our employment services business in Canada, recording a loss of $ 1.0 million. We previously recorded an impairment charge of $ 2.9 million related to these assets.
(3) Other expenses includes credits and costs that are not allocated to a particular segment. This includes expenses incurred as part of our acquisitions, as well as potential acquisitions which have not been or may not be completed.


11
4. REVENUE RECOGNITION
We recognize revenue as, or when, we satisfy performance obligations under a contract. The majority of our contracts have performance obligations that are satisfied over time. In most cases, we view our performance obligations as promises to transfer a series of distinct services to our customers that are substantially the same and which have the same pattern of service. We recognize revenue over the performance period as a customer receives the benefits of our services.
Disaggregation of Revenue
In addition to our segment reporting, we disaggregate our revenues by contract type and customer type. Our operating segments represent the manner in which our Chief Executive Officer reviews our financial results, which is further discussed in "Note 3. Business Segments."
Table 4.1: Revenue by Contract Type
For the Three Months Ended
December 31, 2023 December 31, 2022
(dollars in thousands)
Performance-based $ 704,711 53.1 % $ 569,217 45.6 %
Cost-plus 342,015 25.8 % 347,319 27.8 %
Fixed price 176,677 13.3 % 175,073 14.0 %
Time and materials 103,638 7.8 % 157,637 12.6 %
Total revenue $ 1,327,041 $ 1,249,246
Table 4.2: Revenue by Customer Type
For the Three Months Ended
December 31, 2023 December 31, 2022
(dollars in thousands)
U. S. federal government agencies $ 662,946 50.0 % $ 603,918 48.3 %
U.S. state government agencies 486,943 36.7 % 437,362 35.0 %
International government agencies 155,612 11.7 % 181,760 14.5 %
Other, including local municipalities and commercial customers 21,540 1.6 % 26,206 2.1 %
Total revenue $ 1,327,041 $ 1,249,246
Contract balances
Differences in timing between revenue recognition and cash collection result in contract assets and contract liabilities. We classify these assets as accounts receivable — billed and billable and unbilled receivables; the liabilities are classified as deferred revenue.
In many contracts, we bill our customers on a monthly basis shortly after the month end for work performed in that month and such balances are considered collectible and are included within accounts receivable, net.
Exceptions to this pattern will arise for various reasons, including those listed below.
• Under cost-plus contracts, we are typically required to estimate a contract's share of our general and administrative expenses. This share is based upon estimates of total costs, which may vary over time. We typically invoice our customers at an agreed provisional billing rate, which may differ from actual rates incurred. If our actual rates are higher than the provisional billing rates, an asset is recorded for this variance; if the provisional billing rates are higher than our actual rates, we record a liability.
• Certain contracts include retainage balances, whereby revenue is earned, but some portion of cash payments are held back by the customer for a period of time, typically to allow the customer to confirm the objective criteria laid out by the contract have been met. This balance is classified as accounts receivable - unbilled until restrictions on billing are lifted. As of December 31, 2023, and September 30, 2023, $ 21.6 million and $ 20.7 million, respectively, of our unbilled receivables related to amounts pursuant to contractual retainage provisions.
12
• In certain contracts, we may receive funds from our customers prior to performing operations. These funds are typically referred to as "set-up costs" and reflect the need for us to make investments in infrastructure prior to providing a service. This investment in infrastructure is not a performance obligation that is distinct from the service that is subsequently provided and, as a result, revenue is not recognized based upon the establishment of this infrastructure, but rather over the course of the contractual relationship. The funds are initially recorded as deferred revenue and recognized over the term of the contract. Other contracts may not include set-up fees but will provide higher fees in earlier periods of the contract. The premium on these fees is deferred.
• Some of our contracts, notably our employment services contracts in the Outside the U.S. Segment, include payments for desired outcomes, such as job placement and job retention, and these outcome payments occur over several months. We are required to estimate these outcome fees ahead of their realization and recognize this estimated fee over the period of delivery.
During the three months ended December 31, 2023, we recognized revenue of $ 37.7 million included in our deferred revenue balances at September 30, 2023. During the three months ended December 31, 2022, we recognized revenue of $ 51.1 million included in our deferred revenue balances at September 30, 2022.
Contract estimates
We are required to use estimates in recognizing revenue from some of our contracts.
Some of our performance-based contract revenue is recognized based upon future milestones defined in each contract. This is the case in many of our employment services contracts in the Outside the U.S. Segment, where we are paid as individuals attain employment milestones, which may take many months to achieve. We recognize revenue over the period of performance. Our estimates vary from contract to contract but may include the number of participants within a portfolio reaching employment milestones and the service delivery periods for participants reaching the employment milestone.
We estimate the total variable fees we will receive using the expected value method. We recognize the fees over the expected period of performance. At each reporting period, we update our estimates of the variable fees to represent the circumstances present at the end of the reporting period. We are required to constrain our estimates to the extent that it is probable that there will not be a significant reversal of cumulative revenue when the uncertainty is resolved. We do not have a history of significant constraints on these contracts.
Changes to our estimates are recognized on a cumulative catch-up basis. For the three months ended December 31, 2023, there was a decrease in revenue and diluted earnings per share of $ 4.6 million and $ 0.07 from changes in estimates. There was no material effect for the three months ended December 31, 2022.
Remaining performance obligations
As of December 31, 2023, we had approximately $ 300 million of remaining performance obligations. We anticipate that we will recognize revenue on approximately 70 % of this balance within the next 12 months. This balance excludes contracts with an original duration of twelve months or less, including contracts with a penalty-free termination for convenience clause, and any variable consideration which is allocated entirely to future performance obligations, including variable transaction fees or fees tied directly to costs incurred.

5. EARNINGS PER SHARE
Table 5: Weighted Average Number of Shares - Earnings Per Share
For the Three Months Ended
December 31, 2023 December 31, 2022
(in thousands)
Basic weighted average shares outstanding 61,322 61,117
Dilutive effect of unvested RSUs and PSUs 213 79
Denominator for diluted earnings per share 61,535 61,196
The diluted earnings per share calculation for the three months ended December 31, 2023 and 2022 excludes approximately 467,000 and 804,000 unvested anti-dilutive restricted stock units, respectively .

13
6. DEBT AND DERIVATIVES
Table 6.1: Details of Debt
December 31, 2023 September 30, 2023
(in thousands)
Term Loan A, due 2026 $ 888,750 $ 909,375
Term Loan B, due 2028 344,052 344,934
Revolver 80,000 —
Subsidiary loan agreements 6,818 3,220
Total debt principal 1,319,620 1,257,529
Less: Unamortized debt-issuance costs and discounts ( 6,934 ) ( 7,536 )
Total debt 1,312,686 1,249,993
Less: Current portion of long-term debt ( 90,443 ) ( 86,844 )
Long-term debt $ 1,222,243 $ 1,163,149
Our credit agreements require us to comply with a number of covenants, including leverage and interest coverage ratios. At December 31, 2023, we are in compliance with all covenants. We do not believe that the covenants represent a significant restriction on our ability to successfully operate the business or to pay dividends.
The following table sets forth future minimum principal payments due under our debt obligations as of December 31, 2023 for the remainder of fiscal year 2024 through fiscal year 2028:
Table 6.2: Details of Future Minimum Principal Payments Due
Amount Due
(in thousands)
January 1, 2024 through September 30, 2024 $ 71,340
Year ended September 30, 2025 92,903
Year ended September 30, 2026 821,028
Year ended September 30, 2027 3,528
Year ended September 30, 2028 330,821
Total Payments $ 1,319,620
Interest Rate Derivative Instruments
To reduce our interest rate credit risk, we entered into interest-rate swap agreements covering $ 650 million of our Term Loan A, effectively setting a fixed rate for a portion of our debt. The balance of the debt pays interest based upon an index. At December 31, 2023, our effective interest rate, including the original issuance costs and discount rate, was 6.0 %.
At December 31, 2023, we recorded an asset of $ 21.2 million and a liability of $ 2.2 million to reflect the fair value of these interest rate swap agreements, compared to an asset of $ 31.0 million at September 30, 2023. The asset and liability are recorded as "other assets" and "other liabilities," respectively, within our consolidated balance sheet.
Our interest rate agreement for a notional amount of $ 150 million expires in September 2024; the remaining balance of our swap agreements expires in May 2026, concurrent with the maturity of Term Loan A.

7. FAIR VALUE MEASUREMENTS
The following assets and liabilities are recorded at fair value on a recurring basis.
• We hold mutual fund assets within a Rabbi Trust to cover liabilities in our deferred compensation plan. These assets have prices quoted within active markets and, accordingly, are classified as level 1 within the fair value hierarchy.
• We have interest rate swap agreements serving to reduce our interest rate risk on our debt. These agreements can be valued using observable data and, accordingly, are classified as level 2 within the fair value hierarchy.
14
• We anticipate paying additional consideration for certain acquisitions based upon the subsequent performance of the businesses acquired. This liability is based upon our internal assumptions over revenues, margins, volumes, and contract terms. Accordingly, these inputs are not observable and are classified as level 3 within the fair value hierarchy.
The tables below present assets and liabilities measured and recorded at fair value in our consolidated balance sheets on a recurring basis and their corresponding level within the fair value hierarchy. No transfers between Level 1, Level 2, and Level 3 fair value measurements occurred for the three months ended December 31, 2023.
Table 7.1: Fair Value Measurements
As of December 31, 2023
Level 1 Level 2 Level 3 Balance
(in thousands)
Assets:
Deferred compensation assets - Rabbi Trust $ 29,126 $ — $ — $ 29,126
Interest rate swap - $ 450 million notional value
— 21,185 — 21,185
Total assets $ 29,126 $ 21,185 $ — $ 50,311
Liabilities:
Interest rate swap - $ 200 million notional value
$ — $ 2,212 $ — $ 2,212
Contingent consideration — — 8,166 8,166
Total liabilities $ — $ 2,212 $ 8,166 $ 10,378
The fair values of receivables, prepaids, other assets, accounts payable, accrued costs, and other current liabilities approximate the carrying values as a result of the short-term nature of these instruments. The carrying value of our debt is consistent with the fair value as the stated interest rates in the agreements are consistent with the current market rates used in notes with similar terms in the markets (Level 2 inputs).
Accumulated Other Comprehensive Loss
All amounts recorded in accumulated other comprehensive loss are related to our foreign currency translations and interest rate swaps, net of tax. The following table shows changes in accumulated other comprehensive loss. Amounts reclassified from other comprehensive income were recorded within our selling, general and administrative expenses (for foreign currency translation adjustments) and within interest expense (for gains on derivatives).
Table 7.2: Details of Changes in Accumulated Other Comprehensive Loss by Category
Foreign currency translation adjustment Net unrealized gain on derivatives, net of tax Total
(in thousands)
Balance as of September 30, 2023 $ ( 50,484 ) $ 22,869 $ ( 27,615 )
Other comprehensive income before reclassifications 5,779 ( 5,801 ) ( 22 )
Amounts reclassified from accumulated other comprehensive loss 133 ( 3,084 ) ( 2,951 )
Net current period other comprehensive losses 5,912 ( 8,885 ) ( 2,973 )
Balance as of December 31, 2023 $ ( 44,572 ) $ 13,984 $ ( 30,588 )
Contingent Consideration
The fair value of our contingent consideration is based upon estimates of the likely payments, which are based upon assumptions over future performance. The liabilities are reviewed on a quarterly basis and, where changes in estimates arise, these are recorded to selling and general administrative expenses.
Our contingent consideration relates to the businesses below:
• In October 2021, we acquired the student loan servicing business from Navient, rebranded as Aidvantage. Future payments are based upon volumes, up to a maximum payment of $ 65.0 million. At December 31, 2023, and September 30, 2023, the Aidvantage contingent consideration was $ 5.6 million and $ 7.5 million, respectively.
15
• In January 2022, we acquired BZ Bodies Limited. Future payments are based upon the performance of the business through December 2023, up to a maximum payment of $ 2.5 million (£ 2.0 million British Pounds). At December 31, 2023, and September 30, 2023, we recorded a contingent consideration liability for the maximum payment, which we anticipate making in fiscal year 2024.
Movement in our contingent consideration balance is as follows:
Table 7.3: Fair Value Measurement Using Significant Unobservable Inputs (Level 3)
Contingent Consideration
(in thousands)
Opening contingent consideration as of September 30, 2023 $ 9,903
Adjustments to fair value recorded in the period 977
Cash payments ( 2,819 )
Foreign currency translations 105
Closing contingent consideration as of December 31, 2023 $ 8,166

8. EQUITY
Stock Compensation
We grant restricted stock units ("RSUs") and performance stock units ("PSUs") to eligible participants under our 2021 Omnibus Incentive Plan, which was approved by the Board of Directors and stockholders. The RSUs granted to employees vest ratably over three to five years and one year for members of the Board of Directors, in each case from the grant date. PSU vesting is subject to the achievement of certain performance and market conditions, and the number of PSUs earned could vary from 0 % to 200 % of the number of PSUs awarded. The PSUs will vest at the end of a three-year performance period. We issue new shares to satisfy our obligations under these plans. The fair value of each RSU and PSU is calculated at the date of the grant.
During the three months ended December 31, 2023, we issued approximately 302,000 RSUs, which will vest ratably over three to four years , and approximately 128,000 PSUs, which will vest after three years .

16
9. OTHER BALANCE SHEET ITEMS
Cash, Cash Equivalents, and Restricted Cash
Table 9.1: Details of Cash and Cash Equivalents and Restricted Cash
December 31, 2023 September 30, 2023
(in thousands)
Cash and cash equivalents $ 104,186 $ 65,405
Restricted cash 49,309 56,686
Cash, cash equivalents, and restricted cash $ 153,495 $ 122,091
Restricted cash is recorded within "Prepaid expenses and other current assets" on the Consolidated Balance Sheets.
Table 9.2: Supplemental Disclosures of Cash Flow Information
For the Three Months Ended
December 31, 2023 December 31, 2022
(in thousands)
Interest payments $ 20,522 $ 19,748
Income tax (refunds)/payments, net $ ( 588 ) $ 4,982
Accounts Receivable, Net
Table 9.3: Details of Accounts Receivable, Net
December 31, 2023 September 30, 2023
(in thousands)
Billed and billable receivables $ 708,145 $ 692,707
Unbilled receivables 160,250 137,885
Allowance for credit losses ( 7,986 ) ( 3,719 )
Accounts receivable, net $ 860,409 $ 826,873
On September 21, 2022, we entered into a Receivables Purchase Agreement with Wells Fargo Bank N.A., under which we may sell certain U.S.-originated accounts receivable balances up to a maximum amount of $ 200.0 million at any given time. In return for these sales, we receive a cash payment equal to the face value of the receivables less a financing charge.
We account for these transfers as sales. We have no retained interest in the transferred receivables other than administrative responsibilities, and Wells Fargo has no recourse for any credit risk. We estimate that the implicit servicing fees for an arrangement of this size and type would be immaterial.
For the three months ended December 31, 2023, the gross fair value of accounts receivables transferred to Wells Fargo and derecognized from our balance sheet was $ 108.2 million. In exchange for these sales, we received $ 107.5 million of cash. The balance, representing a loss on sale from these transfers, is included within our selling, general and administrative expenses. We have recorded these transactions within our operating cash flows.

17
10. COMMITMENTS AND CONTINGENCIES
Litigation
We are subject to audits, investigations, and reviews relating to compliance with the laws and regulations that govern our role as a contractor to agencies and departments of federal, state, local, and foreign governments. Adverse findings could lead to criminal, civil, or administrative proceedings, and we could be faced with penalties, fines, suspension, or debarment. Adverse findings could also have a material adverse effect on us because of our reliance on government contracts. We are subject to periodic audits by federal, state, local, and foreign governments for taxes. We are also involved in various claims, arbitrations, and lawsuits arising in the normal conduct of our business. These include but are not limited to bid protests, employment matters, contractual disputes, and charges before administrative agencies. Although we can give no assurance, based upon our evaluation and taking into account the advice of legal counsel, we do not believe that the outcome of any existing matter would likely have a material adverse effect on our consolidated financial position, results of operations, or cash flows.
We evaluate, on a regular basis, developments in our litigation matters and establish or make adjustments to our accruals as appropriate. A liability is accrued if a loss is probable and the amount of such loss can be reasonably estimated. If the risk of loss is probable, but the amount cannot be reasonably estimated, or the risk of loss is only reasonably possible, a potential liability will be disclosed but not accrued, if material. Due to the inherent uncertainty in the outcome of litigation, our estimates and assessments may prove to be incomplete or inaccurate and could be impacted by unanticipated events and circumstances, adverse outcomes, or other future determinations.
MOVEit Cybersecurity Incident Litigation
As the Company has previously disclosed, on May 31, 2023, Progress Software Corporation, the developer of MOVEit (“MOVEit”), a file transfer application used by many organizations to transfer data, announced a critical zero-day vulnerability in the application that allowed unauthorized third parties to access its customers’ MOVEit environments. Maximus uses MOVEit for internal and external file sharing purposes, including to share data with government customers related to Maximus's services in support of certain government programs. Based on its review of the impacted files to date, the Company has provided notices to individuals whose personal information, including social security numbers, protected health information, and/or other personal information, may have been included in the impacted files.
On August 1, 2023, a purported class action was filed against Maximus Federal Services, Inc. (a wholly-owned subsidiary of Maximus, Inc.) in the U.S. District Court for the Eastern District of Virginia arising out of the MOVEit cybersecurity incident – Bishop v. Maximus Federal Services, Case No. 1:23-cv-01019 (U.S. Dist. Ct. E. D. VA). The plaintiff, who purports to represent a nationwide class of individuals, alleges, among other things, that the Company’s negligence resulted in the compromise of the plaintiff’s personally identifiable information and protected health information.
Since August 1, 2023, approximately ten additional cases arising out of the MOVEit cybersecurity incident have been filed in federal courts against Maximus, Inc. and its subsidiaries. The most recent case, Forsyth ex rel. S.F. v. Maximus, Inc., et al., No. 1:24-cv-10218-ADB was filed January 26, 2024. These cases each allege substantially similar allegations on behalf of putative nationwide classes and on behalf of various putative state subclasses.
On October 4, 2023, the United States Judicial Panel on Multidistrict Litigation granted a Motion to Transfer that created a Multidistrict Litigation (“MDL”) in the District of Massachusetts for all cases in federal court related to the MOVEit cybersecurity incident, including cases filed against Maximus and other defendants, including Progress Software Corporation, the creator of MOVEit. All of the cases against Maximus, Inc. and its subsidiaries initially filed in federal courts outside of the District of Massachusetts that are related to the MOVEit cybersecurity incident have now been transferred to the MDL under the caption In re: MOVEit Customer Data Security Breach Litigation and are currently stayed pending the filing of consolidated amended compliant(s). The plaintiffs in Bishop and the other cases against the company in the MDL seek damages to be proved at trial. The Company is not able to determine or predict the ultimate outcome of these proceedings or reasonably provide an estimate or range of the possible outcome or loss, if any.
On September 6, 2023, an individual action was filed in state court in the Florida Circuit Court for the 7th Judicial Circuit, Volusia County: Taylor v. Maximus Federal Services, Case No. 2023-12349 (Fla. Cir. Ct., 7th Jud. Cir., Volusia Cnty.), also arising out of the MOVEit cybersecurity incident. The plaintiff alleges, among other things, that the Company’s negligence resulted in the compromise of the plaintiff’s personally identifiable information and protected health information. Since September 6, 2023, approximately eight additional individual actions have been filed against Maximus, Inc. and its subsidiaries in Florida state courts, one of which has been dismissed. These actions all raise substantially similar allegations and legal claims. The plaintiffs in these individual actions seek damages to be proved at trial. The Company is not able to determine or predict the ultimate outcome of these proceedings or reasonably provide an estimate or range of the possible outcome or loss, if any.
18
On October 27, 2023, a purported class action was filed in state court in Marion Superior Court in Marion County, Indiana, against Maximus Health Services, Inc. (a wholly owned subsidiary of Maximus, Inc.): Solis Garcia v. Maximus Health Services, Inc., Case No. 49D12-2310-CT-042115 (Ind. Super. Ct., Marion Cnty.), again arising out of the MOVEit cybersecurity incident. The plaintiff, who purports to represent a class comprised of Indiana residents, alleges, among other things that the Company’s negligence resulted in the compromise of the plaintiff’s personally identifiable information and protected health information. The plaintiff seeks damages to be proved at trial. The Company has removed this case to federal court in the Southern District of Indiana and requested that it be transferred to the MDL. The Company is not able to determine or predict the ultimate outcome of any of these proceedings or reasonably provide an estimate or range of the possible outcome or loss, if any.
The Company is not able to determine or predict the ultimate outcome of any of these proceedings or reasonably provide an estimate or range of the possible outcome or loss, if any.
Census Project – Civil Investigation Demand (“CID”)
In 2021, Maximus received a CID from the U.S. Department of Justice (“DOJ”) pursuant to the False Claims Act seeking records pertaining to the Census project. The CID requested the production of documents related to the Company’s compliance with telephone call quality assurance scoring and reporting requirements. The Company is cooperating with the DOJ in its investigation and providing responses and information on an ongoing basis. As of December 31, 2023, the Company has reserved $ 3.0 million in connection with this matter. While it is reasonably possible that losses exceeding the amount accrued may be incurred, it is not possible at this time to estimate the additional possible loss in excess of the amount already accrued.

11. SUBSEQUENT EVENT
On January 5, 2024, our Board of Directors declared a quarterly cash dividend of $ 0.30 for each share of our common stock outstanding. The dividend is payable on February 29, 2024, to shareholders of record on February 15, 2024. Based upon the number of shares outstanding, we anticipate a cash payment of approximately $ 18.3 million.
19
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with "Risk Factors," "Special Note Regarding Forward-Looking Statements," and our financial statements and related notes included in our Annual Report on Form 10-K for fiscal year 2023 filed with the Securities and Exchange Commission on November 16, 2023 (the "2023 Form 10-K") and elsewhere in this Quarterly Report on Form 10-Q, as applicable.
Business Overview
Maximus, under its mission of Moving People Forward, helps millions of people access the vital government services they need. With over 45 years of experience working with local, state, federal, and international government clients, we proudly design, develop, and deliver innovative and impactful programs that change lives. We are driven to strengthen communities and improve the lives of those we serve.
We create value to our customers through our ability to translate health and human services public policy into operating models that achieve outcomes for governments at scale. Our work covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. These services benefit from a market with increasing demographic demand, constrained government budgets, and an increased focus on technology. We have also shown the ability to move quickly, most notably with the swift establishment of public health and safety initiatives during the recent COVID-19 pandemic, such as vaccine information hotlines and unemployment insurance services. Our organic growth through increased contract scope and entry into new markets has been supplemented by strategic acquisitions. Most notably, our recent acquisitions of VES Group, Inc. ("VES"), a leading provider of medical disability examinations ("MDE") to the United States ("U.S.") Department of Veterans Affairs ("VA"); the Federal business of Attain, LLC ("Attain"), a provider of technology consulting and systems integration services; and a service contract with the U.S. Department of Education, rebranded as "Aidvantage," have supplemented our organic growth and allowed expansion into new markets.
In fiscal year 2022, we introduced our refreshed three-to-five-year strategic plan, which we believe will further expand our business. Having moved past the impacts of the COVID-19 pandemic, we believe we are in a strong position to capitalize on organic growth opportunities in our core business, as reflected in the following three pillars of our refreshed strategy.
• Customer Services, Digitally Enabled. Elevate the customer experience to achieve higher levels of satisfaction, performance, and outcomes through intelligent automation and cognitive computing.
• Future of Health. Help governments reach the rising demand for health services by growing our clinical capabilities to improve the health of people and their communities.
• Advanced Technologies for Modernization . Further our credibility as a technology leader, enabling the transformation of government programs to be resilient, dynamic, integrated, and equitable.
20
Financial Overview
A number of factors have affected our results for the first quarter of fiscal year 2024. More detail on these changes is presented below within our "Results of Operations" section.

Results of Operations
The following table sets forth items from our consolidated statements of operations for the three months ended December 31, 2023 and December 31, 2022.
Table MD&A 1: Consolidated Results of Operations
For the Three Months Ended
December 31, 2023 December 31, 2022
(dollars in thousands, except per share data)
Revenue $ 1,327,041 $ 1,249,246
Cost of revenue 1,026,987 1,004,499
Gross profit 300,054 244,747
Gross profit percentage 22.6 % 19.6 %
Selling, general, and administrative expenses 169,195 146,452
Selling, general, and administrative expenses as a percentage of revenue 12.7 % 11.7 %
Amortization of intangible assets 23,349 23,518
Operating income 107,510 74,777
Operating margin 8.1 % 6.0 %
Interest expense 21,507 21,606
Other expense/(income), net 488 (266)
Income before income taxes 85,515 53,437
Provision for income taxes 21,367 13,442
Effective tax rate 25.0 % 25.2 %
Net income $ 64,148 $ 39,995
Earnings per share:
Basic $ 1.05 $ 0.65
Diluted $ 1.04 $ 0.65
Our business segments have different factors driving revenue fluctuations and profitability. The sections that follow cover these segments in greater detail. Our revenue reflects fees earned for services provided. Cost of revenue consists of direct costs related to labor and related overhead, subcontractor labor, outside vendors, rent, and other direct costs. The largest component of cost of revenue, approximately two-thirds, is labor, including subcontracted labor.
Table MD&A 2: Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended December 31, 2023
Revenue Cost of Revenue Gross Profit
Dollars % Change Dollars % Change Dollars % Change
(dollars in thousands)
Three Months Ended December 31, 2022 $ 1,249,246 $ 1,004,499 $ 244,747
Organic effect 86,799 6.9 % 32,835 3.3 % 53,964 22.0 %
Disposal of businesses (13,736) (1.1) % (14,608) (1.5) % 872 0.4 %
Currency effect compared to the prior period 4,732 0.4 % 4,261 0.4 % 471 0.2 %
Three Months Ended December 31, 2023 $ 1,327,041 6.2 % $ 1,026,987 2.2 % $ 300,054 22.6 %


21
Selling, general, and administrative expenses ("SG&A")
Selling, general, and administrative expenses ("SG&A") consist of indirect costs related to general management, marketing, and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. Corporate costs are allocated to segments on a consistent and rational basis. Fluctuations in our SG&A are primarily driven by changes in our administrative cost base, which is not directly driven by changes in our revenue. As part of our work for the U.S. federal government and many states, we allocate these costs using a methodology driven by the U.S. Federal Cost Accounting Standards.
Our SG&A expense increased by $22.7 million year-over-year, primarily driven by growth in our business, including additional spending in anticipation of future work.
Amortization of intangible assets
Our intangible asset amortization for the three months ended December 31, 2023 is consistent with the comparative period in fiscal year 2023.
On December 15, 2023, the Department of Health and Human Services publicly announced that the Centers for Medicare & Medicaid Services (CMS) will recompete the Call Center Operations (CCO) contract to include a labor harmony agreement. We are currently in the second option period of the contract and have operated the program since 2018. No timeline has been disclosed on future actions by the government, including a Request For Proposal release date. Until a recompete process is complete, which typically takes a year or more for a contract of this size and complexity, we expect to continue work uninterrupted on the current contract.
Our balance sheet includes a $41.6 million customer-relationship intangible asset with a five-year remaining life related to this contract which was part of the 2018 acquisition of General Dynamics Information Technology (GDIT) contact centers. In the event that our expectations change with respect to this contract, the value of this asset or its estimated remaining life may need to be adjusted.
Interest Expense
Our interest expense has remained consistent year-over-year as declines in our debt balance are offset by increased interest rates. We have mitigated our risk by fixing interest rates on approximately half of our debt and our near-term capital allocation plan continues to prioritize reducing our debt using our free cash flow.
Provision for Income Taxes
Our effective income tax rate for the three months ended December 31, 2023 and 2022, was 25.0% and 25.2%, respectively. For fiscal year 2024, we expect the effective tax rate to be between 24.5% and 25.5%.
U.S. Federal Services Segment
Our U.S. Federal Services Segment delivers end-to-end solutions that help various U.S. federal government agencies better deliver on their mission, including program operations and management, clinical services, and technology solutions. This segment also includes appeals and assessments services, system and application development, Information Technology ("IT") modernization, and maintenance services. Certain state-based assessments and appeals work that is part of the segment's heritage continues to be managed within this segment. Under Technology Consulting Services ("TCS"), the segment executes on its digital strategy to deliver technology solutions that advance agency missions, including the challenge to modernize, provide better customer experience, and drive process efficiencies. The segment continues to expand its clinical solutions through VES, which manages the clinical evaluation process for U.S. veterans and service members on behalf of the U.S. Department of Veterans Affairs ("VA").
22
Table MD&A 3: U.S. Federal Services Segment - Financial Results
For the Three Months Ended
December 31, 2023 December 31, 2022
(dollars in thousands)
Revenue $ 677,078 $ 618,167
Cost of revenue 520,416 495,473
Gross profit 156,662 122,694
Selling, general, and administrative expenses 87,855 71,649
Operating income 68,807 51,045
Gross profit percentage 23.1 % 19.8 %
Operating margin percentage 10.2 % 8.3 %
Our revenue and cost of revenue for the three months ended December 31, 2023, increased 9.5% and 5.0%, respectively, compared to the three months ended December 31, 2022. All growth in the first quarter of fiscal year 2024 was organic.
As anticipated, much of this growth was driven by increased volumes on expanded programs, including the U.S. Department of VA's Medical Disability Examinations ("MDE") contracts.
Our profit margins have improved period-over-period. Our results in the first quarter of fiscal year 2023 reflected hiring and staffing costs in anticipation of higher volumes, thus tempering margins. Our results in fiscal year 2024 reflect those anticipated volumes. We anticipate full-year operating margin will range between 11% and 12%.
U.S. Services Segment
Our U.S. Services Segment provides a variety of business process services ("BPS"), such as program administration, assessments, and related consulting work for U.S. state and local government programs. These services support a variety of programs, including the Affordable Care Act ("ACA"), Medicaid, the Children's Health Insurance Program ("CHIP"), Temporary Assistance to Needy Families ("TANF"), and child support programs. Over the last three years, many programs in this segment have been operating with depressed margins resulting from the pause in Medicaid redeterminations. The depressed margins have resulted from reduced operating leverage in the segment as costs could not scale down at the same rate to meet lower demand due to requirements to fulfill other obligations on these contracts. Now that redetermination activities have resumed, we expect fiscal year 2024 and beyond to reflect a recovery of operating leverage.
Table MD&A 4: U.S. Services Segment - Financial Results
For the Three Months Ended
December 31, 2023 December 31, 2022
(dollars in thousands)
Revenue $ 489,845 $ 439,478
Cost of revenue 371,482 355,880
Gross profit 118,363 83,598
Selling, general, and administrative expenses 52,300 45,842
Operating income 66,063 37,756
Gross profit percentage 24.2 % 19.0 %
Operating margin percentage 13.5 % 8.6 %
Our revenue and cost of revenue for the three months ended December 31, 2023, increased 11.5% and 4.4%, respectively, compared to the three months ended December 31, 2022. All growth in the first quarter of fiscal year 2024 was organic.
This segment received the benefit of expanded eligibility support and clinical services programs, as well as the resumption of Medicaid redetermination activities.
Profit margins in fiscal year 2023 reflected the pause in redetermination activities, which have since been resumed. We anticipate our full-year operating margin will range between 11% and 12%.

23
Outside the U.S. Segment
Our Outside the U.S. Segment provides BPS for international governments, transforming the lives of people around the world. Helping people find employment, access vital support, and remain healthy, these services include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. We support programs and deliver services in the United Kingdom, including the Health Assessment Advisory Service ("HAAS") and the recently awarded replacement contract to start in 2024, Functional Assessment Services (“FAS”), and Restart; Australia, including Workforce Australia and employment support and job seeker services worldwide.
Table MD&A 5: Outside the U.S. Segment - Financial Results
For the Three Months Ended
December 31, 2023 December 31, 2022
(dollars in thousands)
Revenue $ 160,118 $ 191,601
Cost of revenue 135,089 153,146
Gross profit 25,029 38,455
Selling, general, and administrative expenses 25,141 28,389
Operating (loss)/income (112) 10,066
Gross profit percentage 15.6 % 20.1 %
Operating margin percentage (0.1) % 5.3 %
Table MD&A 6: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue and Gross Profit
Revenue Cost of Revenue Gross Profit
Amount % Change Amount % Change Amount % Change
(dollars in thousands)
Three Months Ended December 31, 2022 $ 191,601 $ 153,146 $ 38,455
Organic effect (22,479) (11.7) % (7,710) (5.0) % (14,769) (38.4) %
Disposal of businesses (13,736) (7.2) % (14,608) (9.5) % 872 2.3 %
Currency effect compared to the prior period 4,732 2.5 % 4,261 2.8 % 471 1.2 %
Three Months Ended December 31, 2023 $ 160,118 (16.4) % $ 135,089 (11.8) % $ 25,029 (34.9) %
This segment recorded a break-even margin in the first quarter of fiscal year 2024 as management undertakes steps to improve performance and deliver consistent profitability in this part of our organization. These steps included the divestiture in fiscal year 2024 of our employment services business in Canada and all of our operations in Italy and Singapore. In fiscal year 2023, we disposed of our commercial practice in the United Kingdom and our Swedish operations.
In the first quarter of fiscal year 2023, this segment received a significant benefit from higher employment services volumes, which did not recur. Revenue from our employment services contracts include payments based upon our ability to place individuals in long-term, sustained employment. We recognize this revenue over the period of performance using estimates of these outcomes, which are typically based upon past performance. Changes in these estimates may have a significant effect on our revenue.
We anticipate our Outside the United States Segment will yield slightly above break-even operating margin for the full year.
Liquidity and Capital Resources
Our primary sources of liquidity are cash on hand, cash from operations, and availability under our revolving credit facilities. As of December 31, 2023, we had $104.2 million in cash and cash equivalents. We believe that our current cash position, access to our revolving debt, and cash flow generated from operations should be sufficient for our operating requirements for the next 12 months and beyond, including enabling us to fund required long-term debt repayments, dividends and any share purchases we might choose to make. See "Note 6. Debt and Derivatives" to the Consolidated Financial Statements for a more detailed discussion of our debt financing arrangements.
24
We have included the following table showing our debt balances as of December 31, 2023, and their effective interest rates.
Table MD&A 7: Balances and interest rates as of December 31, 2023
December 31, 2023
Carrying value Effective cash interest rate Interest rate basis
(dollars in thousands)
Term Loan A - Unhedged $ 238,750 6.96 % Term SOFR reset monthly plus margin. (1)
Term Loan A - Hedged though May 2026 500,000 3.91 % Fixed rate of 2.31% plus margin. (1)
Term Loan A - Hedged through September 2024 150,000 5.98 % Fixed rate of 4.48% plus margin. (1)
Term Loan B 344,052 7.46 % Term SOFR (variable reset) plus 2% margin.
Revolver 80,000 6.96 % Term SOFR reset monthly plus margin. (1)
Debt held by international subsidiaries 6,818 6.14 % Floating rate, reset quarterly.
Debt Principal $ 1,319,620
(1) Applicable margin ranges between 1% and 2%, based on our leverage ratio.
Our effective cash interest rate reflects the drivers of our cash interest payments as of December 31, 2023, which can change based upon the reset of the rates. Including the amortization of the upfront payments, our effective interest rate as of December 31, 2023 is 6.0%.
The below table summarizes our change in cash, cash equivalents, and restricted cash.
Table MD&A 8: Net Change in Cash and Cash Equivalents and Restricted Cash
For the Three Months Ended
December 31, 2023 December 31, 2022
(in thousands)
Operating activities:
Net cash provided by/(used in) operating activities $ 21,608 $ (134,659)
Net cash used in investing activities (20,432) (15,697)
Net cash provided by financing activities 28,382 170,967
Effect of foreign exchange rates on cash and cash equivalents and restricted cash 1,846 2,421
Net change in cash and cash equivalents and restricted cash $ 31,404 $ 23,032
Net Cash Provided By/Used In Operating Activities
Net cash from operations was $21.6 million in the first quarter of fiscal year 2024, compared with a cash outflow of $134.7 million in the first quarter of fiscal year 2023.
• Cash collections were stronger than usual in the the first quarter of the current year, with our Days Sales Outstanding ("DSO") remaining steady between September 30, 2023, and December 31, 2023 at 60 days and 59 days, respectively. Our DSO at September 30, 2022 and December 31, 2022, were 62 days and 74 days, respectively, with slower payments in the first quarter catching up in the second quarter of fiscal year 2023.
• In fiscal year 2023, we also made payroll tax payments that had been deferred as part of pandemic-related relief measures, as well as higher income tax payments, which did not occur in the first quarter of fiscal year 2024.
Net Cash Used In Investing Activities
Investing activities in the first quarter of fiscal years 2024 and 2023 include significant investments in internal-use software, as well as standard purchases of property and equipment. In the first quarter of fiscal year 2024, we received payments for the sale of businesses disposed of in the quarter, as well as an installation on the sale of our United Kingdom commercial practice.

25
Net Cash Provided By Financing Activities
Our net borrowings in the first quarter of fiscal year 2024 were lower than the same prior year period, due to the improved cash collections.
Credit Facilities
Our principal debt agreement is with JPMorgan Chase Bank N.A. (the "Credit Agreement"). At December 31, 2023, we owed $1.31 billion under the Credit Agreement, with access to an additional $520 million through a revolving credit facility. Mandatory repayments are required under this agreement through May 2028, when the agreement ends, and must be renegotiated or the funds repaid.
The Credit Agreement contains a number of covenants with which we are expected to comply. Failure to meet these requirements would result in a need to renegotiate the agreement or a requirement to repay our outstanding debt in full. There are two financial covenants, both defined in the Credit Agreement.
• Our Consolidated Net Total Leverage Ratio means, for any twelve-month period, the ratio of our Funded Debt, offset by up to $75 million of unrestricted cash (Consolidated Total Leverage), against our Consolidated EBITDA (as defined by the Credit Agreement). To comply with our Credit Agreement, this ratio cannot exceed 4.00:1.00 at the end of each quarter, with a step up to 4.50:1.00 under certain circumstances. This ratio also determines both our interest rate and the charge we pay on the unused component of our revolving credit facility, with the charge increasing as the leverage ratio increases.
• Our Consolidated Net Interest Coverage Ratio means, for any twelve-month period, the ratio of our Consolidated EBITDA against our Consolidated Net Interest Expense as defined by the Credit Agreement. To comply with our Credit Agreement, this ratio cannot be less than 3.00:1.00 at the end of each quarter.
Consolidated EBITDA also drives certain permissions within the Credit Agreement, such as the level of investment we are entitled to make without seeking additional approval from our lenders.
Our Credit Agreement defines Consolidated EBITDA, as well as other components of the calculations above. The definition of Consolidated EBITDA requires us to include adjustments not typically included within EBITDA, including unusual, non-recurring expenses, certain non-cash adjustments, the pro forma effects of acquisitions and disposals, and estimated synergies from acquisitions. As a result, Consolidated EBITDA as defined by the Credit Agreement may not be comparable to EBITDA or related or similarly-titled measures presented by other companies.
We have summarized below the components of our two financial ratio calculations, including the components of Consolidated EBITDA as defined by the Credit Agreement, which are included within our financial statements. At December 31, 2023, we were in compliance with all applicable covenants of our Credit Agreement. We do not believe that these covenants represent a significant restriction in our ability to operate our business or to pay our dividends.
Table MD&A 9: Reconciliation of Net Income to Consolidated EBITDA as defined by our Credit Agreement
For the Three
Months Ended 		For the Trailing Twelve
Months Ended
December 31, 2023 December 31, 2023
(in thousands)
Net income $ 64,148 $ 185,945
Adjustments:
Interest expense 21,507 84,039
Other expense, net 488 1,117
Provision for income taxes 21,367 56,426
Amortization of intangibles 23,349 94,422
Stock compensation expense 9,427 34,546
Acquisition-related expenses 1,724 905
Loss on sale of businesses 1,018 1,901
Depreciation and amortization of property, equipment, and capitalized software 8,411 50,856
Pro forma and other adjustments permitted by our Credit Agreement 13,940 70,202
Consolidated EBITDA (as defined by our Credit Agreement) $ 165,379 $ 580,359
26
Table MD&A 10: Consolidated Net Total Leverage Ratio
For the Trailing Twelve
Months Ended
December 31, 2023
(in thousands, except ratio data)
Funded Debt (as defined by our Credit Agreement) $ 1,319,620
Cash and cash equivalents up to $75 million 75,000
Consolidated Net Total Leverage (as defined by our Credit Agreement) $ 1,244,620
Consolidated Net Total Leverage Ratio (as defined by our Credit Agreement) 2.14
Table MD&A 11: Consolidated Net Interest Coverage Ratio
For the Trailing Twelve
Months Ended
December 31, 2023
(in thousands, except ratio data)
Consolidated EBITDA (as defined by our Credit Agreement) $ 580,359
Interest expense 84,039
Components of other income/expense, net allowed in ratio calculation 3,061
Consolidated Net Interest Expense (as defined by our Credit Agreement) 87,100
Consolidated Net Interest Coverage Ratio (as defined by our Credit Agreement) 6.66
Cash in Foreign Locations
We have no requirement to remit funds from our foreign locations to the United States. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds, as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.
Free Cash Flow (Non-GAAP)
Table MD&A 12: Free Cash Flow (Non-GAAP)
For the Three Months Ended
December 31, 2023 December 31, 2022
(in thousands)
Net cash provided by/(used in) operating activities $ 21,608 $ (134,659)
Purchases of property and equipment and capitalized software (22,247) (15,697)
Free cash flow (Non-GAAP) $ (639) $ (150,356)

27
Critical Accounting Policies and Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires us to make estimates, judgments, and assumptions that affect the amounts reported. Actual results could differ from those estimates. The 2023 Form 10-K, as filed with the SEC on November 16, 2023, includes a summary of critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenues, or expenses during the three months ended December 31, 2023.

Non-GAAP and Other Measures
We utilize non-GAAP measures where we believe it will assist users of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, cash flows from operating activities, net income, or earnings per share as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.
For the three months ended December 31, 2023, 12% of our revenue was generated outside the U.S. We believe that users of our financial statements wish to understand the performance of our foreign operations using a methodology that excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current fiscal period's results for all foreign businesses using the exchange rates in the prior fiscal period.
In recent years, we have made a number of acquisitions and divestitures. We believe users of our financial statements wish to evaluate the performance of our operations, excluding changes that have arisen due to businesses acquired or disposed of. We identify acquired revenue and cost of revenue by showing these results for periods for which no comparative results exist within our financial statements. We identify revenue and cost of revenue that has been disposed of in a similar manner. This information is supplemented by our calculations of organic growth. To calculate organic growth, we compare current fiscal period results excluding transactions from acquisitions or disposals, to our prior fiscal year period results.
Our recent acquisitions have resulted in significant intangible assets, which are amortized over their estimated useful lives. We believe users of our financial statements wish to understand the performance of the business by using a methodology that excludes the amortization of our intangible assets. For the three months ended December 31, 2023, we also incurred losses on sales of businesses. We believe that providing supplemental measures that exclude the impact of the items detailed below is useful to investors in evaluating our core operations and results in relation to past periods. Accordingly, we have calculated our operating income, net income, and diluted earnings per share, excluding the effect of the amortization of intangible assets and divestiture-related charges. We have included a table showing our reconciliation of these income measures to their corresponding GAAP measures.
28
Table MD&A 13: Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets
For the Three Months Ended
December 31, 2023 December 31, 2022
(dollars in thousands, except per share data)
Operating income $ 107,510 $ 74,777
Add back: Amortization of intangible assets 23,349 23,518
Add back: Divestiture-related charges 1,018 —
Adjusted operating income excluding amortization of intangible assets and divestiture-related charges (Non-GAAP) $ 131,877 $ 98,295
Adjusted operating income margin excluding amortization of intangible assets and divestiture-related charges (Non-GAAP) 9.9 % 7.9 %
Net income $ 64,148 $ 39,995
Add back: Amortization of intangible assets, net of tax 17,208 17,360
Add back: Divestiture-related charges 1,018 —
Adjusted net income excluding amortization of intangible assets and divestiture-related charges (Non-GAAP) $ 82,374 $ 57,355
Diluted earnings per share $ 1.04 $ 0.65
Add back: Effect of amortization of intangible assets on diluted earnings per share 0.28 0.29
Add back: Effect of divestiture-related charges on diluted earnings per share 0.02 —
Adjusted diluted earnings per share excluding amortization of intangible assets and divestiture-related charges (Non-GAAP) $ 1.34 $ 0.94
In order to sustain our cash flows from operations, we regularly refresh our fixed assets and technology. We believe that users of our financial statements wish to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology that combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of our operations and replacement capital expenditures and excludes the cash flow effects of acquisitions, purchases of our common stock, dividend payments, and other financing transactions. We have provided a reconciliation of cash flows from operations to free cash flow in "Liquidity and Capital Resources."
To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements wish to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days.
29
Item 3. Quantitative and Qualitative Disclosures About Market Risk
In the normal course of business, we are exposed to financial risks such as changes in interest rates, foreign currency exchange rates, and counterparty risk. We use derivative instruments to manage selected interest rate exposures. The Company's market rate risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" on the 2023 Form 10-K, as filed with the SEC on November 16, 2023, have not changed materially during the three month period ended December 31, 2023.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
30
PART II - Other Information
Item 1. Legal Proceedings
Refer to our disclosures included in " Note 10. Commitments and Contingencies " included in Part 1, Item 1 of this Quarterly Report on Form 10-Q.
Item 1A. Risk Factors
There were no material changes during the three months ended December 31, 2023, to the risk factors previously disclosed in the 2023 Form 10-K, as filed with the SEC on November 16, 2023.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(a) None.
(b) None.
(c) None.
Item 3. Defaults Upon Senior Securities
(a) None.
(b) None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
(a) None.
(b) None.
(c) During the three months ended December 31, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as follows:

• David W. Mutryn , our Chief Financial Officer , adopted a new Rule 10b5-1 trading arrangement on November 17, 2023 that is scheduled to terminate on February 29, 2024. Under the trading arrangement, up to an aggregate of 8,000 shares of common stock are available to be sold by the broker on a particular date.

• Michelle Link , our Chief Human Resources Officer , adopted a new Rule 10b5-1 trading arrangement on December 15, 2023 that is scheduled to terminate on December 2, 2024. Under the trading arrangement, up to an aggregate of 5,588 shares of common stock are available to be sold by the broker on particular dates, subject to adjustment based on the vesting of performance awards.
31
Item 6. Exhibits
Exhibit
No. 		Description of Exhibit
v
v
Φ
Φ
101.INS v Inline XBRL Instance Document.
101.SCH v Inline XBRL Taxonomy Extension Schema Document.
101.CAL v Inline XBRL Taxonomy Calculation Linkbase Document.
101.DEF v Inline XBRL Taxonomy Definition Linkbase Document.
101.LAB v Inline XBRL Taxonomy Label Linkbase Document.
101.PRE v Inline XBRL Taxonomy Presentation Linkbase Document.
104 v Cover Page Interactive Data File. (formatted as Inline XBRL tags and contained in Exhibit 101)
v Filed herewith.
Φ Furnished herewith.
32
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Maximus, Inc.
/s/ Bruce L. Caswell February 8, 2024
By: Bruce L. Caswell
President and Chief Executive Officer
(Principal Executive Officer)
/s/ David W. Mutryn February 8, 2024
By: David W. Mutryn
Chief Financial Officer
(Principal Financial Officer)
33
TABLE OF CONTENTS